Lazard Asset Management »

Intellia Therapeutics shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.1M 102k 30.49
2023-09-30 $3.4M 106k 31.61
2023-06-30 $4.4M 108k 40.78
2023-03-31 $4.0M 107k 37.27
2022-12-31 $1.7M 48k 34.88
2022-09-30 $4.9M 87k 55.95
2022-06-30 $4.3M 82k 51.76
2022-03-31 $0 549 0.00
2021-12-31 $40k 403 100.00
2021-09-30 $1.0k 10 100.00